Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study to evaluate the effect of efavirenz coadministration on the pharmacokinetics of the active moieties of a combined oral contraceptive containing ethinyl estradiol and norgestimate [ethinylestradiol/norgestimate] in healthy female subjects.

Trial Profile

Study to evaluate the effect of efavirenz coadministration on the pharmacokinetics of the active moieties of a combined oral contraceptive containing ethinyl estradiol and norgestimate [ethinylestradiol/norgestimate] in healthy female subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2011

At a glance

  • Drugs Efavirenz; Ethinylestradiol/norgestimate
  • Indications HIV infections; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 02 Nov 2007 Status changed from in progress to completed.
    • 15 Jun 2007 Status changed from recruiting to in progress.
    • 24 Dec 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top